News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Prevention of mother-to-child transmission news

Show

From To
Hepatitis B
Sixfold increased risk of infant HIV infection and high rates of low birth weight among women with HIV/hepatitis B co-infection

Women with high levels of hepatitis B viraemia (>106IU/ml) who have co-infection with HIV had a more than sixfold increased risk of having infants with HIV infection

Published
12 March 2019
By
Carole Leach-Lemens
Prevention of mother-to-child transmission
Integrase inhibitors give greater chance of viral suppression at delivery in pregnant women

Integrase inhibitor-based treatment with either raltegravir (Isentress) or dolutegravir (Tivicay, also in Triumeq) reduces viral load more rapidly than efavirenz if started in pregnancy, findings from

Published
06 March 2019
By
Keith Alcorn
Achieving the 90-90-90 target
CROI 2019: Thailand’s strides spanned HIV treatment, prevention and research

he first HIV vaccine trials to yield signs of hope happened here. Thailand was also the first Asian country to eliminate mother-to-child transmission of HIV. Now, Thailand has achieved the first part of UNAIDS’ 90-90-90 targets: 98 percent of people infected with HIV know their status.

Published
06 March 2019
From
Science Speaks
Infant feeding
Mismatch between US infant feeding policies and the lived experience of HIV-positive women

US guidelines recommending that HIV-positive women feed their infants formula milk instead of breast milk create unique challenges for patients and healthcare providers alike, according to a mixed-methods

Published
26 February 2019
By
Krishen Samuel
Child developmental issues
South Africa urgently needs an antiretroviral pregnancy registry

With the dolutegravir roll-out around the corner, the time is now ripe for patients and activists to demand a prospective pregnancy registry for the whole of South Africa. Whether it is a new endeavour or piggy-backs on international efforts is a matter for debate, but it is the only way we can answer the question of dolutegravir’s safety with the minimum number of women being exposed to the drug. It’s the least that patients deserve.

Published
29 January 2019
From
Spotlight
Child developmental issues
Efavirenz in pregnancy is at least as safe as other antiretrovirals

An individual patient data analysis of almost 25,000 pregnancies in women living with HIV has found that the rate of birth defects following exposure to efavirenz was

Published
17 January 2019
By
Roger Pebody
Prevention of mother-to-child transmission
New BHIVA guidelines on HIV care in pregnancy and after birth

New British HIV Association (BHIVA) guidelines on the management of HIV in pregnancy have been issued this month, emphasising the continuing scientific uncertainty over HIV transmission through

Published
05 December 2018
By
Keith Alcorn
Bad science and bogus treatments
As A Strategy for HIV Prevention, Disabling the CCR5 Gene in Embryos Implanted in HIV-Negative Mothers Makes Zero Sense

Here are a bunch of things we know about HIV prevention. You’ll note that nowhere on this list is anything about preventing HIV in babies born to women who don’t have the virus to begin with — because the babies are not at risk, even if the mother’s male sexual partner has HIV.

Published
03 December 2018
From
NEJM Journal Watch
Bad science and bogus treatments
Gene editing won’t help the fight against HIV, understanding one’s risk and prevention options will

Andrew Chidgey says HIV positive men and women can already have HIV negative babies through the use of medication and some well-recognised precautions. This negates the need for gene editing to prevent transmission of HIV and raises ethical questions about a Chinese scientist’s recently announced research.

Published
01 December 2018
From
South China Morning Post
Prevention of mother-to-child transmission
Children, HIV and AIDS: The world today and in 2030

The world pledged to end AIDS by 2030. While we have seen remarkable progress in the past decade among children aged 0-9 years, adolescents have been left behind in HIV prevention efforts. A staggering 360,000 adolescents are projected to die of AIDS-related diseases between 2018 and 2030 without additional investment in HIV prevention, testing and treatment programs.

Published
30 November 2018
From
UNICEF
← Prev12345...44Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.